Docetaxel is marketed worldwide under the name Taxotere by Sanofi-Aventis [6] as well as Docefrez by Sun Pharma Global and Zytax by Zydus.[7] Annual sales of Taxotere in 2010 were Euro 2.122 billion ($US 3.1 billion). The patent expired in 2010.[citation needed]

https://en.wikipedia.org/wiki/Docetaxel